| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |